Related Experiment Video
Updated: Dec 11, 2025

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
Published on: May 25, 2022
Melkersson-Rosenthal Syndrome Induced by COVID-19
Bahadır Taşlıdere1, Liljana Mehmetaj1, Ayşe Büşra Özcan1
1Department of Emergency Medicine, Bezmialem Vakıf University School of Medicine, İstanbul, Turkey.
Abstract:
Melkersson-Rosenthal syndrome is a rare condition characterized by a triad of orofacial edema, facial paralysis, and fissured tongue. Histopathological examination of the disease has demonstrated areas of inflammation involving mast cells. Activated mast cells also play a part in the pathogenesis of COVID-19 infection, as they release cytokines in the lungs. We present a case of a female patient presenting with edema. We present a case of a female patient presenting with edema. Her examination revealed edema in the right lower lip, right facial paralysis, and fissured tongue. COVID-19 may be associated with which was not previously included in the etiology of the disease.
Insights
Melkersson-Rosenthal syndrome, a rare condition, may be linked to COVID-19. This association is suggested by mast cell involvement observed in both conditions, highlighting a potential new factor in the syndrome's etiology.
Area of Science:
- Neurology
- Immunology
- Dermatology
Background:
- Melkersson-Rosenthal syndrome is a rare neurological disorder characterized by orofacial edema, facial paralysis, and fissured tongue.
- Mast cells are implicated in the inflammatory processes of Melkersson-Rosenthal syndrome.
- Mast cell activation is also a known factor in the pathogenesis of COVID-19.
Observation:
- A case study of a female patient presenting with symptoms consistent with Melkersson-Rosenthal syndrome is detailed.
- The patient exhibited edema in the right lower lip, right facial paralysis, and a fissured tongue.
- This presentation occurred in the context of COVID-19.
Findings:
- The study highlights the potential role of mast cells in linking Melkersson-Rosenthal syndrome and COVID-19.
- Activated mast cells release cytokines, contributing to inflammation in both conditions.
- This suggests a possible novel association between the viral infection and the syndrome.
Implications:
- The findings suggest that COVID-19 may be an associated factor in the etiology of Melkersson-Rosenthal syndrome.
- This expands the understanding of potential triggers for this rare condition.
- Further research is warranted to explore this connection and its clinical significance.
More Related Videos
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Myocarditis III: Medical Management
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Endocarditis II: Clinical Features of Infective Endocarditis

